Varitrinox

Varitrinox Uses, Dosage, Side Effects, Food Interaction and all others data.

Varitrinox is a chemotherapeutic agent of idiopathic function used to treat leukemia that is unresponsive to first line agents. It is suspected that arsenic trisulfide induces cancer cells to undergo apoptosis. In general, arsenic is known to be a naturally toxic substance capable of eliciting a variety of dangerous adverse effects. The enzyme thioredoxin reductase has recently been identified as a target for arsenic trioxide.

Arsenic Trioxide is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy.

Trade Name Varitrinox
Generic Arsenic trioxide
Arsenic trioxide Other Names Acide Arsenieux, Anhydride Arsenieux, Arsenic Blanc, Arsenic oxide, Arsenic trioxide, Arsenic(III) oxide, arsénico trióxido, Arsenigen Saure, Arsenolite, Arsenous oxide, Arsenous oxide anhydride, Diarsenic oxide, Diarsenic trioxide, White arsenic
Type
Formula As2O3
Weight Average: 197.84
Monoisotopic: 197.827934
Protein binding

75% bound

Groups Approved, Investigational
Therapeutic Class
Manufacturer
Available Country Argentina
Last Updated: September 19, 2023 at 7:00 am
Varitrinox
Varitrinox

Uses

Varitrinox is a chemotherapeutic agent used in the treatment of refractory or relapsed acute promyelocytic leukemia in patients with prior retinoid and anthracycline chemotherapy.

For induction of remission and consolidation in patients with acute promyelocytic leukemia (APL), and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression

Varitrinox is also used to associated treatment for these conditions: Refractory Acute Promyelocytic Leukemia

How Varitrinox works

The mechanism of action of Arsenic Trioxide is not completely understood. Varitrinox causes morphological changes and DNA fragmentation characteristic of apoptosis in NB4 human promyelocytic leukemia cells in vitro. Varitrinox also causes damage or degradation of the fusion protein PML/RAR-alpha. It is suspected that arsenic trioxide induces cancer cells to undergo apoptosis.

Toxicity

Symptoms of overdose include convulsions, muscle weakness and confusion.

Food Interaction

No interactions found.

Elimination Route

Trivalent arsenic is mostly methylated in humans and excreted in urine.

Innovators Monograph

You find simplified version here Varitrinox

*** Taking medicines without doctor's advice can cause long-term problems.
Share